Sol-gel technologies announces fda acceptance for filing of new drug application for epsolay

Sol-gel technologies announces fda acceptance for filing of new drug application for epsolay® for the treatment of inflammatory lesions of rosacea.sol gel technologies ltd - pdufa goal date set for april 26, 2021.
SLGL Ratings Summary
SLGL Quant Ranking